Paid Clinical Trials in Austin, TX
As of July 2026, 682 paid clinical trials are recruiting in Austin, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Austin offers studies at sites including Dell Children's Medical Center of Central Texas for conditions such as Obesity, Heart Failure, Breast Cancer, Endometrial Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Austin
Trials by drug in Austin
Filter results
Newly added in Austin
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
609 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Top Research Study Locations in Austin
Researchers run research studies in Austin, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dell Children's Medical Center of Central Texas | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 33 |
| University of Texas at Austin | Stroke, Alcohol Drinking, Alzheimer Disease | 22 |
| The University of Texas at Austin | Attention Deficit Hyperactivity Disorder, Healthy, Multiple Sclerosis | 21 |
| FutureSearch Trials of Neurology | Osteoarthritis, Knee, Chronic Pain, Migraine | 14 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, HIV Infections, Asthma | 12 |
| Texas Cardiac Arrhythmia Research Foundation | Atrial Fibrillation, Heart Failure, Paroxysmal AF | 12 |
| Austin Heart | Heart Failure, Obesity, Heart Failure With Preserved Ejection Fraction | 10 |
| Dell Children's Medical Center | AAOCA, Acute Treatment of Migraine, Adolescent Idiopathic Scoliosis | 10 |
| NEXT Austin | Advanced Solid Tumors, Endometrial Cancer, Advanced Solid Tumor | 10 |
| Urology Austin | Prostate Cancer, Non-Muscle Invasive Bladder Neoplasms, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 10 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Advanced or Metastatic Renal Cell Carcinoma | 9 |
| Texas Oncology - Central/South Texas | Acinar Cell Carcinoma, Advanced Cancer, Advanced Non-Small Cell Lung Cancer | 8 |
| Austin Clinical Trial Partners | Major Depressive Disorder, Depression, Major Depressive Disorder (MDD) | 8 |
| Texas Oncology | Multiple Myeloma, Any Solid Oral Medication, CRC (Colorectal Cancer) | 8 |
| Austin Retina Associates | Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-related Macular Degeneration (AMD) | 7 |
| St. David's South Austin Medical Center | AML, MDS, Multiple Myeloma | 7 |
| Ascension Texas Cardiovascular | Aortic Valve Stenosis, Cardiovascular Diseases, Pulmonary Hypertension | 6 |
| IMA Clinical Research Austin | Obesity, Overweight, Liver Fibrosis | 6 |
| NEXT Oncology | Breast Cancer, Locally Advanced (Unresectable) or Metastatic Solid Tumors, Ovarian Cancer | 6 |
| National Neuromuscular Research Institute | Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis | 6 |
| University of Texas | Logopenic Progressive Aphasia, Logopenic Progressive Aphasia (LPA), Logopenic Variant Primary Progressive Aphasia | 6 |
| Austin Neuromuscular Center | Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP) | 5 |
| Austin Clinical Research, LLC | Diabetic Macular Edema, Geographic Atrophy, Macular Edema | 5 |
| Dell Children's Blood and Cancer Center | Neuroblastoma, Medulloblastoma, Pediatric Cancer | 5 |
| Dell Seton Medical Center at The University of Texas | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 5 |
Active & Upcoming Studies in Austin (2026)
Recruiting trials in Austin grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (174 active studies)
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors · Phase 1 · Cogent Biosciences, Inc.
Mental health & behavior (48 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Self-Compassion, Health, and Empowerment · Yang Li
Diabetes & metabolic (48 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (48 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Cardiovascular (43 active studies)
- Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation · Boston Scientific Corporation
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Eye & vision (24 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Pediatric (13 active studies)
- Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements · Kenneth Moise MD
- Pressure Targeting During High Flow Therapy in Premature Infants · Phase 2 · University of Texas at Austin
Vaccines (4 active studies)
- Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older · Phase 1, Phase 2 · Sanofi
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. · Phase 1 · ModeX Therapeutics, An OPKO Health Company
HIV / STI (3 active studies)
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) · Phase 3 · Merck Sharp & Dohme LLC
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV · Phase 1 · ViiV Healthcare
Common conditions studied in Austin
- Obesity (18 active studies)
- Heart Failure (15 active studies)
- Breast Cancer (13 active studies)
- Endometrial Cancer (13 active studies)
- Overweight (13 active studies)
- Schizophrenia (13 active studies)
Leading research sponsors in Austin
- University of Texas at Austin
- AbbVie
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Austin?
There are approximately 682 recruiting clinical trials in Austin, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Austin pay participants?
Most recruiting trials in Austin compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Austin?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Austin?
The most common conditions under active study in Austin include Obesity (18), Heart Failure (15), Breast Cancer (13), Endometrial Cancer (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Austin?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Austin on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Austin?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Austin?
Recruiting research sites in Austin include Dell Children's Medical Center of Central Texas, University of Texas at Austin, The University of Texas at Austin, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Austin right now?
The largest active categories in Austin are Cancer & tumors (174), Mental health & behavior (48), Diabetes & metabolic (48). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.